Webb12 apr. 2024 · We administered macrophages with F.n OMVs or F.n OMVs pretreated with DNA-nase, RNA-nase, and protein-nase to deplete the DNA, RNA, and protein in F.n OMVs, respectively. Notably, protein-eliminated F.n OMVs, rather than nucleic acid-eliminated F.n OMVs, inhibited the F.n OMV-stimulated inflammation ( Figure 4 A). Webb1 aug. 2024 · PSA-triggered drug delivery. PSA, also known as glutamate carboxypeptidase II (GCPII), is the most prominent biomarker of prostate cancer for …
Recent progress in development of siRNA delivery vehicles
WebbRozema, D. B., Blokhin, A. V., Wakefield, D. H., Benson, J. D., Carlson, J. C., Klein, J. J., … Lewis, D. L. (2015). Protease-triggered siRNA delivery vehicles. WebbProtease-triggered siRNA delivery vehicles (Q87139180) From Wikidata. Jump to navigation Jump to search. scientific article published on 14 April 2015. edit. Language … the guardian legit
Protease-triggered siRNA delivery vehicles
Webb10 juli 2015 · Protease-sensitive polymer masking reagents derived from polyethylene glycol (PEG), which inhibit membrane interactions, and N-acetylgalactosamine, which … Webb9 juli 2010 · The siRNA-based antiviral approach has the following advantages of traditional antiviral compounds: (i) It is a highly potent antiviral agent with preventive as well as therapeutic value; (ii) It can be designed and synthesized in hours, and new ones can be rapidly deployed if resistance to the first set is encountered; (iii) It can be applied … Webb23 sep. 2014 · For systemic delivery of siRNA to solid tumors, a size-regulated and reversibly stabilized nanoarchitecture was constructed by using a 20 kDa siRNA-loaded unimer polyion complex (uPIC) and 20 nm gold nanoparticle (AuNP). the barber shop dickson city